Yannick Simoni
Singapore, 228208, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 15, 2026
High frequency of CD95+/CD45RA- regulatory T cells defines an immunosuppressive profile associated with MDS progression.
Journal: British journal of haematology
Published: December 01, 2025
Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia.
Journal: Communications biology
Published: April 02, 2025
Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesothelioma.
Journal: Translational lung cancer research
Published: April 01, 2024
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.
Journal: HemaSphere
Published: January 31, 2024
In-depth analysis of human virus-specific CD8+ T cells delineates unique phenotypic signatures for T cell specificity prediction.
Journal: Cell reports
Published: March 10, 2023
Bystander CD4+ T cells infiltrate human tumors and are phenotypically distinct.
Journal: Oncoimmunology
Published: December 16, 2022
Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications.
Journal: Diagnostics (Basel, Switzerland)
Published: June 06, 2022
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome.
Journal: Journal for immunotherapy of cancer
Published: June 02, 2022
Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 21, 2021
Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 06, 2020
Last Updated: 09/26/2026